T. Rowe Price Investment Management, Inc., a registered investment adviser, initiated a new position in Elanco Animal Health Incorporated (NYSE:ELAN) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 35,227,418 shares of the Healthcare company, valued at approximately $797.2M as of the filing date.
Elanco Animal Health Incorporated's stock currently trades at $27.12 with a market capitalization of $10.6B.